
|Videos|August 26, 2021
Part 2: Practical Considerations For Venetoclax in AML
Expert continues discussion on important considerations for the optimal use if venetoclax in patients with AML, such as CYP3A4 and p-glycoprotein drug interactions.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bepirovirsen Shows Breakthrough Potential for Functional Cure in Chronic Hepatitis B
2
New Federal Dietary Guidelines Emphasize Protein and Real Foods While Cutting Sugar
3
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
4
'High-Stakes Headaches': Why Pharmacists May be Key to Better Headache Management
5














































































































































































































